nejm Semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, has well-established weight-loss benefits. Cagrilintide, a long-acting analogue of the satiety hormone amylin, has shown promise for weight loss in early trials. The potential US$ 21.78 Min. order: 1 piece ★★★★★ 4.0 (167 reviews) Sold : Login>>
Triple Agonism Based Therapies for Obesity | Current Cardiovascular Risk Reports US$ 23.60 Min. order: 1 piece ★★★★★ 4.5 (84 reviews) Sold : Login>>
What is the pipeline for future medications for obesity? US$ 24.94 Min. order: 1 piece ★★★★★ 4.6 (239 reviews) Sold : Login>>